- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Complex gastro-oesophageal reflux disease; Scleroderma oesophagus; Gastro-oesophageal reflux disease; Peptic ulcer.
- Meeting Date: March 2022
- Public Summary Document (PSD) March 2022 PBAC Meeting - (PDF 416KB)
- Public Summary Document (PSD) March 2022 PBAC Meeting - (Word 60KB)
Rabeprazole – March 2022
Rabeprazole: Tablet containing rabeprazole sodium 20 mg (enteric coated); Pariet®
Last updated
1 July 2022